## SRE: Sempra - XLU: Utilities

### Executive Summary

No thesis match: MRS_10 -0.9% below STRENGTH zone (3.0-6.0%); PEG 1.90 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($84.33)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bearish (Bullish: 0, Bearish: 1)

**1. Sempra (SRE) Estimates A $471 million After-Tax Impact To Earnings From Track 2 Proposed Decision**
- Source: Yahoo Finance UK | 20260104T222600 | Bearish | Relevance: 100%
- Sempra (SRE) anticipates a $471 million after-tax earnings impact due to a Track 2 proposed decision affecting its San Diego Gas & Electric subsidiary. This charge for Q4 2025 includes $34 million for the current year and $437 million for 2019-2024. Despite this, analysts from UBS and Morgan Stanley have adjusted price targets for Sempra, which is considered one of the most significant utility companies in the U.S.

**2. Sempra (SRE) Estimates A $471 million After-Tax Impact To Earnings From Track 2 Proposed Decision**
- Source: Yahoo Finance | 20260104T212600 | Somewhat-Bearish | Relevance: 100%
- Sempra (NYSE: SRE) estimates a $471 million after-tax impact to its earnings due to a Track 2 proposed decision, as reported in a regulatory filing by TheFly. This estimated charge for San Diego Gas & Electric, a subsidiary, includes $34 million for the first three quarters of 2025 and $437 million for the period 2019-2024. The final impact may vary based on future regulatory decisions anticipated in 2026, while analysts at UBS and Morgan Stanley recently lowered their price targets for Sempra.

**3. A Look At Ameren (AEE) Valuation As New Earnings Growth Outlook And Analyst Targets Emerge**
- Source: Simply Wall Street | 20260105T112814 | Neutral | Relevance: 63%
- Ameren (AEE) has provided new long-term earnings growth guidance of 6% to 8% annually from 2025 through 2029, alongside updated analyst views. The stock is currently trading at $100.86, representing a 10.66% discount to the average analyst price target of $111.62, which is supported by expectations of expanding regulated rate base and constructive regulatory relationships. However, a Discounted Cash Flow (DCF) model suggests Ameren might be overvalued with a fair value of $88.10, highlighting a divergence in valuation perspectives.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | UBS | $96 | $98 | -2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | UBS | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 5 ($1.79M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.6% (+14.2%)
- Blackrock Inc.: 9.3% (-4.8%)
- Capital Internationa: 8.3% (+9.2%)
- Wellington Managemen: 7.7% (-3.9%)
- State Street Corpora: 5.4% (+1.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.90 elevated, pricing in significant growth expectations. Forward P/E 17.2x stretched relative to 8% growth. Quality metrics strong (margin 16%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($1.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $57.1B |
| Beta | 0.75 |
| 52W Range | $61.90 - $95.72 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.90 |
| Forward P/E | 17.2 |
| Current P/E | 18.6 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.1% to -0.9% (-1.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.9pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). RSI neutral at 42. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.89% (CS: 26) | Neutral |
| RSI_14 | 42.0 | Neutral |
| MACD Histogram | 0.14 | Bullish |
| vs SMA20 | 0.990x | Below |
| vs SMA50 | 0.965x | Below |
| vs SMA200 | 1.071x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $87.57
- **Stop Loss:** $84.33 (3.7% risk)
- **Target:** $90.81 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 354
- **Position Value:** $30,999.78
- **Portfolio %:** 31.00%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-24 (Est: $1.25)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.91 | $1.11 | +21.7% |
| 2025Q2 | $0.85 | $0.89 | +4.8% |
| 2025Q1 | $1.32 | $1.44 | +9.3% |
| 2024Q4 | $1.55 | $1.50 | -3.3% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_10*